Abstract:As previously reported, we have synthesized an azo azomethine ligand 4-((E)-(2,5 dichloro phenyl) diazenyl)−2-((E)-((4-hydroxyphenyl) imine) methyl) phenol (L). The synthesized ligand has been used to prepare copper(II), nickel(II), and cobalt(II) metal complexes and characterized using various analysis techniques. To identify complexes, methods, such as elemental analyses, electrical conductivity, IR spectroscopy, mass spectrometry, magnetic moment, vibrating sample magnetometry (VSM), 1HNMR, UV–Vis, and thermal analysis were utilized, and a mononuclear structure was proposed for all compounds and all the complexes are non-electrolytes in nature. The chelation of the ligands to the metal ions occurs through phenolic oxygen and nitrogen atoms of the azomethine group of the ligands. According to various analytical and spectral data, a square planar structure is proposed for copper and nickel metal complexes and a quadrilateral structure is proposed for cobalt complexes. The antibacterial properties of ligands and complexes of copper(II), nickel(II), and cobalt(II) were investigated in vitro on standard bacteria as well as on bacteria isolated from clinical specimens (urine). The results revealed that the ligand and its metal complexes had a very high antibacterial activity against Staphylococcus aureus, but were ineffective against other studied bacteria. The synergistic effect of the compounds with the three antibiotics (vancomycin (V), methicillin (M), and trimethoprim (T)) was also investigated, along with the cytotoxicity of its ligand and copper complex in HFF cell line. At a concentration of 3.90 μl of these compounds, cell viability was significant. The structure of ligand and complexes was optimized by DFT calculations. Computational methods were performed for deeper understanding of the interaction between ligands and metal by EDA calculations. This result confirmed that the bonding between ligands to metal was mainly covalent. The complexes investigated are reported for the first time. The search for new antimicrobial agents against Staphylococcus aureus is an urgent medical need. Therefore, sensitive and selective diagnosis of this pathogenic bacterium is of great importance, which has been obtained in this study. The compounds synthesized from among the nine gram-negative and gram-positive bacteria are only sensitive to Staphylococcus aureus bacteria.

Copper (II) complexes with some antibiotics: synthesis, FT-IR study and in vitro antibacterial activity

Synthesis, characterization and antibacterial activity of copper(ii) and nickel(ii) complexes with 3, 10-dialkyl-1, 3, 5, 8, 10, 12 hexaazacyclotetradecane ligand

Anion Induced Synthesis and Crystal Structures of Schiff Base Copper(II) and Zinc(II) Complexes with Antibacterial Activity

New Copper Complexes with Antibacterial and Cytotoxic Activity

New copper(II) cyclam complexes with aminocarboxylate co-ligands: Synthesis, characterization, and in vitro antiproliferative and antibacterial studies

Novel Zinc(II) and Copper(II) Complexes of 2-((2-Hydroxyethyl)amino)quinoline-3-carbaldehyde for Antibacterial and Antioxidant Activities: A Combined Experimental, DFT, and Docking Studies

Coordination and redox interactions of β-lactam antibiotics with Cu2+ in physiological settings and the impact on antibacterial activity

Investigation of the inherent characteristics of copper(II) Schiff base complexes as antimicrobial agents

Copper (II) complexes with (E)-N′(3,5-di-tert-butyl-2-hydroxybenzilidene)-2-hydroxybenzohydrazide, their bactericidal and fungicidal activity

Copper(II) and silver(I) complexes with dimethyl 6-(pyrazine-2-yl)pyridine-3,4-dicarboxylate (py-2pz): the influence of the metal ion on the antimicrobial potential of the complex

Novel copper complexes of metronidazole and metronidazole benzoate: synthesis, characterization, biological and computational studies

Synthesis, Crystal Structure, Antibacterial And Antitumor Activities Of A New Binuclear Copper(Ii) Complex With 1,10-Phen And Fluoroquinolone

Nickel(II), copper(II) and zinc(II) complexes containing symmetrical Tetradentate Schiff base ligand derived from 3,5-diiodosalicylaldehyde: Synthesis, characterization, crystal structure and antimicrobial activity

Syntheses, Crystal Structures and Antitumor Activity of Ni((II)/Zn(II) Complexes Containing Cephalexin Hydrolysate

Synthesis, Crystal Structure, Antibacterial And Antitumor Activities Of A New Binuclear Copper (Ii) Complex Containing Fluoroquinolone

Synthesis, Characterization, and Antibacterial Evaluation of Copper(ii) Complexes Supported by Phenylacetic Acid Derivatives, and Diamine Ligands

Synthesis, Structural Characterization, in Vitro Biological Activity, and Computational Quantum Chemical Studies of New Cobalt (II), Nickel (II), and Copper (II) Complexes Based on an Azo-Azomethine Ligand

Preparation, Characterization, DFT Calculations, Antibacterial and Molecular Docking Study of Co(II), Cu(II), and Zn(II) Mixed Ligand Complexes

Syntheses, Crystal Structures and Antibacterial Activities of Copper(Ii) and Zinc(Ii) Complexes Based on (E)-4-fluoro-2-((3-morpholinopropylimino)methyl)phenol

Experimental and computational insights into antibacterial and antioxidant properties of metal complexes with isoniazid-based Schiff base ligands

The Antibacterial Activity of Copper(II) and Nickel(II) Coordinated Compounds Containing a Polyaza Macrocyclic Ligand